HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Franco Taroni Selected Research

Type 2a1 Axonal Charcot-Marie-Tooth Disease

1/2009A novel founder mutation in the MFN2 gene associated with variable Charcot-Marie-Tooth type 2 phenotype in two families from Southern Italy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Franco Taroni Research Topics

Disease

11Friedreich Ataxia (Friedreich's Ataxia)
01/2020 - 07/2003
8Neurodegenerative Diseases (Neurodegenerative Disease)
10/2021 - 05/2004
7Huntington Disease (Huntington's Disease)
11/2021 - 06/2009
6Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2022 - 05/2004
5Peripheral Nervous System Diseases (PNS Diseases)
01/2020 - 02/2003
4Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2014 - 02/2008
3Paraplegia (Spastic Paraplegia)
11/2021 - 04/2010
3Disease Progression
01/2020 - 10/2014
3Seizures (Absence Seizure)
11/2019 - 04/2005
3CADASIL
09/2017 - 01/2013
3Cerebellar Ataxia (Dysmetria)
01/2012 - 05/2004
2Parkinsonian Disorders (Parkinsonism)
01/2022 - 12/2018
2Hereditary Spastic Paraplegia
11/2021 - 03/2009
2Cognitive Dysfunction
10/2021 - 01/2021
2Optic Atrophy
01/2020 - 12/2018
2autosomal recessive 1 Spinocerebellar ataxia
11/2019 - 08/2011
2Cardiomyopathies (Cardiomyopathy)
06/2019 - 10/2004
2Epilepsy (Aura)
01/2019 - 04/2005
2Ataxia (Dyssynergia)
01/2016 - 10/2014
2Periventricular Nodular Heterotopia
09/2006 - 04/2005
1Type 2F Charcot-Marie-Tooth disease
01/2021
1Bilateral Vestibulopathy
01/2021
1Hypogonadism (Hypergonadotropic Hypogonadism)
01/2021
1Diabetic Neuropathies (Diabetic Neuropathy)
01/2020
1Optic Nerve Diseases (Optic Neuropathy)
01/2020
1Type 2B Charcot-Marie-Tooth disease
01/2020
1Pontocerebellar Hypoplasia
01/2020
1Starvation
01/2020
1Microcephaly
11/2019
1Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy)
06/2019
1Neurilemmoma (Schwannoma)
01/2019
1Hereditary Optic Atrophies
12/2018
1Spastic Ataxia
12/2018
1Alcoholism (Alcohol Abuse)
10/2018
1Multiple System Atrophy
01/2018
1Hypertension (High Blood Pressure)
01/2018
1Amyloidosis
01/2017
1Hereditary Corneal Dystrophies
01/2017
1Cranial Nerve Diseases (Cranial Nerve Disorders)
01/2017
1Cutis Laxa
01/2017
1Facial Paralysis (Facial Palsy)
01/2017
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
05/2016
1Sneddon Syndrome (Syndrome, Sneddon)
05/2016
1Livedo Reticularis
05/2016
1Cerebrotendinous Xanthomatosis
04/2016
1Spinal muscular atrophy with respiratory distress 1
11/2014
1Late Onset Disorders
10/2014
1Agranulocytosis (Granulocytopenia)
10/2014

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2006
10FrataxinIBA
01/2020 - 07/2003
5Pharmaceutical PreparationsIBA
01/2019 - 04/2005
4CholesterolIBA
11/2021 - 04/2016
4EnzymesIBA
01/2020 - 01/2009
4Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2018 - 07/2003
3polyglutamineIBA
01/2022 - 01/2012
3tributyl phosphate (TBP)IBA
01/2022 - 11/2007
3IronIBA
08/2014 - 01/2009
2coenzyme Q10 (CoQ10)IBA
01/2020 - 08/2011
2LipidsIBA
04/2016 - 10/2004
2Gap Junction beta-1 ProteinIBA
06/2014 - 02/2003
2ErythropoietinFDA Link
08/2013 - 03/2012
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2013 - 03/2006
2Free RadicalsIBA
01/2013 - 12/2009
2Myelin P0 Protein (Myelin Protein Zero)IBA
12/2012 - 03/2006
1alpha-SynucleinIBA
01/2022
1Dopamine Receptors (Dopamine Receptor)IBA
11/2021
1Glucosylceramidase (Glucocerebrosidase)IBA
11/2021
1Phospholipases (Phospholipase)IBA
01/2021
1alpha-Crystallins (alpha-Crystallin)IBA
01/2021
1Growth Hormone (Somatotropin)IBA
01/2021
1GTP Phosphohydrolases (GTPases)IBA
01/2020
1Adenosine Triphosphatases (ATPase)IBA
01/2020
1Adenosine Triphosphate (ATP)IBA
01/2020
1Glutamic Acid (Glutamate)FDA Link
01/2020
1Amino AcidsFDA Link
01/2020
1PeripherinsIBA
01/2020
1Carrier Proteins (Binding Protein)IBA
01/2020
1polyolIBA
01/2020
1Sorbitol (Yal)FDA Link
01/2020
1FructoseIBA
01/2020
1Glutamine (L-Glutamine)FDA Link
01/2020
1Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA
01/2020
1Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA
11/2019
1Prealbumin (Transthyretin)IBA
06/2019
1FilaminsIBA
01/2019
1Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA
01/2019
1Ion Channels (Ion Channel)IBA
01/2019
1Caveolin 3IBA
01/2019
1Dynamins (Dynamin)IBA
12/2018
1Levodopa (L Dopa)FDA LinkGeneric
12/2018
1m-AAA proteasesIBA
12/2018
1Vasodilator Agents (Vasodilators)IBA
01/2018
1Diazoxide (Hyperstat)FDA Link
01/2018
1GelsolinIBA
01/2017
1Anticardiolipin AntibodiesIBA
05/2016
1Cholestanetriol 26-Monooxygenase (Cholestanetriol 26 Monooxygenase)IBA
04/2016
1DNA (Deoxyribonucleic Acid)IBA
10/2014

Therapy/Procedure

2Activities of Daily Living (ADL)
10/2014 - 08/2014
1Injections
10/2021
1Therapeutics
09/2017